logo
Microplastics shed by food packaging are contaminating our food and drink, study finds

Microplastics shed by food packaging are contaminating our food and drink, study finds

CNN24-06-2025
Food & health
Corporate news
PollutionFacebookTweetLink
Follow
Ripping the plastic wrap from the meat or prepackaged fruit and veggies you purchased at the grocery store may contaminate your food with micro- and nanoplastics, according to new research.
Plastic contamination may also occur when you're unwrapping deli meat and cheese, steeping a tea bag in hot water, or opening cartons of milk or orange juice. Glass bottles and jars with a plastic-coated metal closure may also shed microscopic bits of plastic, the study found.
In fact, the abrasion from repeatedly opening and closing the caps on glass and plastic bottles can release an untold amount of micro- and nanoplastics into the beverage, said Lisa Zimmermann, lead author of the study published Tuesday in the journal NPJ Science of Food.
'The research shows the number of microplastics increases with each bottle opening, so therefore we can say it's the usage of the food contact article which leads to micro- and nanoplastic release,' said Zimmermann, scientific communication officer at the Food Packaging Forum, a nonprofit foundation based in Zurich, Switzerland, that studies chemicals in food contact materials.
Researchers have measured micro- and nanoplastics in such food and drink products as beer, canned fish, rice, mineral water, tea bags, table salts, take-out foods and soft drinks, according to the study.
'This is the first systematic evidence of how normal and intended use of foodstuffs packaged in plastics can be contaminated with micro- and nanoplastics,' Zimmermann said. 'We found food packaging is actually a direct source of the micro- and nanoplastics measured in food.'
A separate investigation by the Food Packaging Forum published in September 2024 found more than 3,600 chemicals leach into consumer products during food manufacturing, processing, packaging and storage, ending up in the human body.
Seventy-nine of those food-processing chemicals are known to cause cancer, genetic mutations, endocrine and reproductive issues, and other health concerns, according to the September 2024 study.
And while scientists have long known about potentially toxic chemicals from plastics leaching into food, 'what's less clear, and deeply concerning, is just how significant food packaging is as a source of exposure to plastic particles and what that means for our health,' said David Andrews, acting chief science officer at the Environmental Working Group, a Washington, DC-based health and environmental advocacy organization, in an email.
'This new study highlights food packaging and processing equipment as potentially significant sources of microplastic contamination in the food we eat, and ultimately in our bodies,' said Andrews, who was not involved with the research. 'This study should raise alarm bells.'
CNN reached out to the Plastics Industry Association for comment but did not hear back before publication.
Microplastics are polymer fragments that can range from less than 0.2 inch (5 millimeters) down to 1/25,000th of an inch (1 micrometer). Anything smaller is a nanoplastic that must be measured in billionths of a meter.
At 1,000th the average width of a human hair, experts say nanoplastics are so teeny they can migrate through the tissues of the digestive tract or lungs into the bloodstream. As the blood circulates, the plastics may distribute potentially harmful synthetic chemicals throughout the body and into cells.
A flurry of recent studies have discovered microplastics and nanoplastics in human brain tissue, the testes and the penis, human blood, lung and liver tissues, urine and feces, mother's milk, and the placenta.
In the first analysis to illustrate harm to human health, a March 2024 study found people with microplastics or nanoplastics in their carotid artery tissues were twice as likely to have a heart attack or stroke or die from any cause over the next three years than people who had none.
The latest research searched thousands of studies to find those that did the best job of identifying and measuring plastics in tested foods before narrowing the list to 103 for the review.
Microplastic research is quite new, and studies so far often use different methods of microplastic identification and measurement. The lack of standard protocol can make it difficult to adequately compare findings, said senior study author Jane Muncke, managing director and chief scientific officer at the Food Packaging Forum.
'The novel aspect of our analysis is we didn't just collect all the studies, but we also examined the scientific reliability of their methods. We included a critical appraisal step,' Muncke said. 'That left us with seven highly reliable studies — more high-quality research is definitely needed.'
According to that research, ultraprocessed foods contain significantly more microplastics than minimally processed foods.
'There's a higher number of manufacturing steps with ultraprocessed foods, which can increase the contact time with plastic food processing equipment,' Muncke said, 'thus increasing the chance of micro- and nanoplastic migration.'
Migration into food also increased when the plastic packaging was heated, washed for reuse, exposed to sunlight and subjected to mechanical stress — such as the twist used to open a bottle cap, according to the review. That sort of repeated stress could lead to higher abrasion than opening a plastic container, so future research should consider how plastic is used as well as the types of plastics, Muncke said.
'This is a rigorous, detailed and critical study that applies robust systematic methods to review the existing literature on microplastics and food contact materials,' said Megan Deeney, a research fellow and doctoral student in plastics and global health at the London School of Hygiene & Tropical Medicine at the University of London, in an email.
'What is particularly important is that the authors take the time to extract and evaluate evidence on whether the presence of microplastics changed over time in these studies — this can help to identify the food contact material itself as a direct source of food contamination by microplastics,' said Deeney, who was not involved with the new research.
One of the studies included in the new review found 1 liter of water — the equivalent of two standard-size bottled waters bought at the store — contained an average of 240,000 plastic particles from seven types of plastics, of which 90% were identified as nanoplastics and the rest were microplastics.
Another example involved melamine, which is used to make bowls, plates, cups and other plastic tableware.
'In one study, researchers washed a melamine bowl 10 times, 20 times, 50 times, 100 times and measured the amount of microplastic it released each time,' Zimmermann said. 'Then they put something in the bowl and tested it and found more microplastic release after increased washing.'
While it's not yet possible to clean microplastics from the food supply, there are steps one can take to reduce exposure to plastics and the chemicals they secrete.
'One is to reduce our plastic footprint by using stainless steel and glass containers, when possible,' said Dr. Leonardo Trasande, director of environmental pediatrics at NYU Langone Health, in an earlier interview with CNN.
'Avoid microwaving food or beverages in plastic, including infant formula and pumped human milk, and don't put plastic in the dishwasher, because the heat can cause chemicals to leach out,' Trasande said.
In addition, check the recycling code on the bottom of packaging to find the plastic type, and avoid plastics with recycling code 3, which typically contain phthalates, he added.
Bring reusable bags to the grocery store, suggests the Natural Resources Defense Council, a New York City-based environmental advocacy group. Invest in a zippered fabric bag and ask the dry cleaner to return your clothes in that instead of those thin sheets of plastic. Bring a travel mug to the local coffee store for takeout and silverware to the office, cutting back on plastic cups and utensils.
However, due to the pervasiveness of microplastics in the environment, 'this is not something that any individual can solve on their own,' Deeney said.
'We need systemic action to reduce plastics production and pollution,' she said via email, encouraging anyone concerned about the issue to send a message to their representatives.
'There's a critical opportunity for individuals to engage with governments to demand strong, ambitious action on plastics in the upcoming final round of negotiations for a Global Plastics Treaty in Geneva this August, where more than 175 countries will convene to determine a legally-binding instrument to end plastics pollution.'
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Help! My Patient Asked Me About Their Smartwatch HRV Status!
Help! My Patient Asked Me About Their Smartwatch HRV Status!

Medscape

time19 minutes ago

  • Medscape

Help! My Patient Asked Me About Their Smartwatch HRV Status!

In recent years, smartwatches have gained popularity across Europe, driven by an increase in health awareness, smartphone integration, and advancements in wearable technology. They are now able to monitor an increasing number of health metrics, including the now-popular heart rate variability (HRV). So what happens when a patient comes to the clinic worried about their HRV status, as reported by their watch? To learn more about HRV and its clinical significance, Medscape Medical News spoke with two experts. Professor Thomas Gronwald, PhD, is head of the Department of Performance, Neuroscience, Therapy and Health at MSH Medical School Hamburg, Germany. He is an exercise and training scientist with a focus on internal and external load analysis in strength and conditioning training. Cailbhe Doherty, PhD, is an assistant professor at the School of Public Health, Physiotherapy, and Sports Science at University College Dublin, Ireland. His research is dedicated to investigating the effectiveness of consumer wearables in public health and the integration of mobile technologies in healthcare systems. What is HRV? And is it possible for smartwatches/wearables to accurately measure it? Thomas Gronwald, PhD Doherty: HRV is the variation in time between successive heartbeats. So even if your heart is beating at 60 beats/min, that doesn't mean it's beating exactly once every second. There are tiny fluctuations between beats — sometimes 0.98 seconds, sometimes 1.02 — and that variation is what we call HRV. Those fluctuations aren't random. They're governed by your autonomic nervous system…and within that system, there's a kind of balance: the sympathetic branch, which speeds things up (fight or flight), and the parasympathetic branch, which slows things down (rest and digest). HRV reflects that balance. In simple terms, a higher HRV generally indicates a more adaptable, resilient nervous system, and it's often used as a proxy for recovery, stress, and overall cardiovascular health. Gronwald: The gold standard for a valid and reliable assessment of the time between two successive heartbeats is the electrocardiogram (ECG), which allows recordings in the laboratory or during daily activity — up to 24 hours or longer. Several mobile and user-friendly measurement systems and wearables exist, which can record R-R intervals with different applications and form factors — chest strap systems, adhesive patches, and electrode systems on the skin — that utilize not only electrophysiologic but also optically derived signals such as photoplethysmography…. Most commercially available portable devices show a low absolute error under resting conditions but should always be validated against reference measures to clarify the accuracy of data parameters and maximize real-world application value. Is HRV an important measure of someone's health? Is it an important measure for an athlete? Doherty: Yes, but with some important qualifications. HRV can be a valuable indicator of health, but it's not a silver bullet. In a general health context, higher HRV is often associated with better cardiovascular health, lower levels of chronic stress, and even reduced risk for mortality…. It's a useful window into your overall resilience. The issue is that HRV is highly individual. What's high for one person might be low for another. It's not the kind of measure where a single value tells the whole story. You really need to look at trends over time and ideally interpret them in the context of things like sleep, recovery, illness, and training load. Gronwald: The usefulness of HRV as an indicator of physiologic and pathologic conditions, for risk stratification, and as a marker of autonomic adaptive and regulatory capacity is evident. However, longitudinal data recordings are recommended when trend analysis with contextual data is intended. Considering the mentioned context-sensitive requirements, HRV analysis allows for longitudinal trend analysis of patients and healthy individuals, including athletic and nonathletic populations in various clinical and performance-related settings. This includes the application of HRV monitoring for resting conditions, during and/or after biofeedback and training interventions, as well as general relationships between recovery status, previous exercise conditions, and symptoms of overreaching and overtraining. What should a doctor do if someone goes to them saying their smartwatch is showing that they continuously have a low HRV status? Cailbhe Doherty, PhD Doherty: I'd suggest it should be treated as a starting point. The physician might ask: Has this person noticed other symptoms — fatigue, poor sleep, high stress? Has their resting heart rate changed? Are there lifestyle factors — alcohol, illness, overtraining, or mental health — that could explain the trend? And if it seems warranted, they could conduct more standardized assessments, such as an ECG-based HRV measurement or a broader autonomic function test. The data is not medical grade and we don't know enough about how the proprietary algorithms are processing the signals. But if the question is whether the HRV trend might reflect something real, then yes, it's possible. Ultimately, I think wearables are better at raising questions than answering them. And that's not a bad thing. Is such data reliable? Gronwald: This depends strongly on the wearable or recording device. The measurement principles and the type of analysis and processing of the biosignal vary significantly between different devices. On the one hand, sleep analyses are used during the night, while on the other hand, context-free time points during the day are often used. Here, care should be taken to include standardized situations for a measurement and interpretation context. It is recommended to use validated measurement systems that either use the entire night as a reference phase or a consistent measurement situation early in the morning after waking up without prior stressors. Both approaches have advantages and disadvantages. How can someone improve their HRV? Gronwald: HRV improves when the body is balanced between activity and recovery within hemodynamic boundaries, with strong support from sleep, stress reduction, and a healthy active lifestyle. Regular physical activity, especially moderate aerobic exercise — such as walking, cycling, or swimming — and strength training can increase HRV over time. Breathing exercises with slow, deep, and diaphragmatic breathing — for example 4-6 breaths per minute — can help to activate the parasympathetic nervous system, which improves HRV. Good sleep quality with consistent sleep patterns, enough deep sleep, and avoiding late-night screen time and activity are essential for higher HRV. Further, stress management and practices such as meditation, social connection, mindfulness, or progressive muscle relaxation are linked to emotional well-being and can reduce stress and therefore improve HRV. Finally, healthy nutrition habits such as a balanced diet rich in whole foods, omega-3 fatty acids, fruits, and vegetables supports HRV — including limitation of stimulants, alcohol, nicotine, and processed foods. How important do you think wearable technology is to support the provision of healthcare across Europe? What role do you think it will play in the future? Doherty: Healthcare systems across Europe are facing enormous pressure: aging populations, rising chronic disease, long waiting lists, and constrained resources. Wearables offer something really compelling in that context: the ability to monitor people continuously, passively, and remotely, outside the clinic, in real-world settings. [But] at the moment, most wearable data isn't integrated into the healthcare system. It lives in consumer ecosystems — Apple, Google, Fitbit, Garmin — and that creates problems around standardization, privacy, and clinical utility. We can't expect a GP or a cardiologist to wade through raw data from 10 different apps and figure out what it means. There are also big equity issues. Most wearables are still designed and validated in relatively narrow populations — usually younger, healthier, often White, middle-income users. If we start using wearable data in clinical decision-making, we need to be absolutely sure it's valid across diverse populations, otherwise we risk baking health inequalities into digital health systems. Another issue is data privacy. When we start linking consumer data to clinical records, the stakes get much higher. Who owns the data? Who profits from it? Who gets access to it? Ultimately, I think wearables will play an increasingly important role in population health monitoring, early detection, and personalized prevention. But for that to happen in a way that is safe, effective, and fair, we need interoperability, regulatory oversight — especially on algorithm transparency, robust validation in real-world populations, and a clear framework around data rights and governance. Gronwald and Doherty reported no relevant financial relationships.

Pfizer battles another Paxlovid lawsuit from Enanta
Pfizer battles another Paxlovid lawsuit from Enanta

Yahoo

timean hour ago

  • Yahoo

Pfizer battles another Paxlovid lawsuit from Enanta

If you don't succeed at first, try again – in separate regions. That's the motto Enanta Pharmaceuticals is following, at least, after disclosing it has sued Pfizer in Europe over a patent infringement relating to Covid-19 treatment pill Paxlovid (nirmatrelvir/ritonavir). In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma company infringed on a patent describing protease inhibitors invented by its scientists. Enanta has now followed that up with another filing in Europe, making the same accusation. Since being emergency authorised in 2021, anti-viral Paxlovid has generated Pfizer more than $26bn in global revenue. This includes a staggering $18.9bn in 2022 when Covid-19 cases were still prevalent. Despite waning demand for Covid-19 treatments, the pill still brought in $1.2bn in 2024, buoyed by government orders. However, Enanta – known for co-developing hepatitis C virus treatment glecaprevir/pibrentasvir with AbbVie – believes Pfizer designed Paxlovid via unlawful means. The US biotech stated it is 'seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's Covid-19 antiviral, Paxlovid'. In an emailed statement to Pharmaceutical Technology, a Pfizer spokesperson said: 'We are confident in our intellectual property (IP) surrounding Paxlovid and will respond in due course in court.' The lawsuit, filed in the European Union's (EU) Unified Patent Court (UPC), targets Pfizer's commercial activity in the 18 countries of the EU. The company confirmed the '265 patent in question is the European counterpart of US patent number 11,358,953 (the '953 Patent) that is the centre of the US lawsuit. Although it is technically ongoing, Enanta's US lawsuit hit a major roadblock. In December 2024, a federal judge in Massachusetts sided with Pfizer, granting that the '953 patent is invalid. Enanta confirmed at the time it would appeal the decision, adding it 'believes strongly in the merits of our case'. Pfizer reported strong Q2 2025 results this month, bucking a tepid earnings window that gripped the wider pharma industry. Sales for the Paxlovid grew 71% while the Covid-19 vaccine Comirnaty revenue surged 95%. However, the legal challenge posed by Enanta marks the second issue Pfizer has had to firefight this week. The big pharma company reported a Phase III trial failure for a sickle cell disease candidate purchased as part of a $5.4bn takeover of Global Blood Therapeutics in 2022. "Pfizer battles another Paxlovid lawsuit from Enanta" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

‘What Doesn't Kill Us' Review: Freeze Your Enthusiasm
‘What Doesn't Kill Us' Review: Freeze Your Enthusiasm

Wall Street Journal

timean hour ago

  • Wall Street Journal

‘What Doesn't Kill Us' Review: Freeze Your Enthusiasm

In 2017 the investigative journalist Scott Carney wrote 'What Doesn't Kill Us.' The book featured Wim Hof, an unorthodox health trainer from Holland who could push people (including Mr. Carney) past previously unthinkable physical barriers. The book became a bestseller and helped transform Mr. Hof into a celebrity, popularizing his training methods—particularly cold plunges, which involve immersing oneself in frigid water for a few minutes at a time. Capitalizing on the sales of 'What Doesn't Kill Us,' in 2020 Mr. Hof wrote his own book, which has been translated into multiple languages. Never mind that Mr. Carney's book came with an ominous full-page disclaimer, warning that the practices described in the book 'are inherently dangerous and could result in grave harm or death.' It's tempting to dismiss the foreboding tone as a publicity stunt to juice sales. But since then, Mr. Carney tells us in a new edition of his book, he has 'collected more than thirty reports of people who have drowned while following Hof's example by practicing his breathwork techniques in water.' In a 15-page afterword to the new edition, Mr. Carney tells us that Mr. Hof's representatives respond by insisting there are warnings—for instance, in the descriptions attached to Mr. Hof's demonstration videos on YouTube—against using his breathing techniques 'in a swimming pool, before going underwater, beneath the shower, or piloting any vehicle.' Mr. Carney isn't convinced, citing a video marketed by Mr. Hof in which he contradicts his own guidance. 'At the very least, the juxtaposition between the written warning and Hof's own words is confusing. At worst, it's a dramatic acknowledgment of the sort of negligence that could get someone killed.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store